GlaxoSmithKline Biologicals SA et al v. Pfizer Inc. et al

Track this case

Case Number:

1:24-cv-00512

Court:

Delaware

Nature of Suit:

Patent

Judge:

Gregory B. Williams

Firms

Companies

Sectors & Industries:

  1. August 20, 2024

    Vax Patent Battles Heat Up As Attention On Pandemic Wanes

    It's been over four years since clinical trials began for COVID-19 vaccines, and while the shots have helped the pandemic recede, the lucrative technology has spurred numerous patent suits, many of which are still in the early stages. Here's a look at some of the key cases in the U.S.

  2. July 25, 2024

    Pfizer Calls GSK Patents In COVID Vax Case Unenforceable

    Pfizer and BioNTech have fired back at GlaxoSmithKline's patent suit against them over the COVID-19 vaccine, saying GSK's patents are unenforceable because the company delayed in filing its applications and then crafted them to cover the blockbuster vaccine after it became available.

  3. April 25, 2024

    GSK Hits Pfizer And BioNTech With COVID Vaccine Patent Suit

    GlaxoSmithKline alleged in a suit filed Thursday in Delaware federal court that the COVID-19 vaccines made by Pfizer and BioNTech infringe five of its patents on mRNA technology, the latest in a series of lawsuits over the vaccines that have generated tens of billions of dollars in revenue.